Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The provided input 'coagulation factor XIa, coagulation factor XIIa, plasma kallikrein' combines three distinct, though related, serine proteases. Coagulation factor XIa, coagulation factor XIIa, and plasma kallikrein are individual components of the contact system that play roles in blood coagulation, inflammation, and kinin generation. For proper structured data extraction, each should be handled as a separate canonical target, as each has unique characteristics, drug interactions, and disease associations despite their functional interplay.
This entry refers to multiple distinct serine proteases involved in the contact system. Drugs targeting these act via inhibition of their respective activities to modulate coagulation, kinin generation, and inflammation. For accurate structured data, each protein should be handled as an individual target.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on coagulation factor XIa, coagulation factor XIIa, plasma kallikrein.